Diagnostic and therapeutic algorithms for monogenic autoinflammatory diseases presenting with recurrent fevers among adults.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 08 2023
Historique:
received: 09 06 2022
accepted: 09 12 2022
medline: 3 8 2023
pubmed: 29 12 2022
entrez: 28 12 2022
Statut: ppublish

Résumé

Autoinflammatory diseases (AIDs) are defined as disorders of innate immunity. They were initially defined in contrast to autoimmune diseases because of the lack of involvement of the adaptive immune system and circulating autoantibodies. The four monogenic AIDs first described are called the 'historical' AIDs and include FMF (associated with MEFV mutations), cryopyrinopathies (associated with NLRP3 mutations), TNF receptor-associated periodic syndrome (associated with TNFRSF1A mutations) and mevalonate kinase deficiency (MKD; associated with MVK mutations). In the last 10 years, >50 new monogenic AIDs have been discovered due to genetic advances. The most important discovery for adult patients is VEXAS syndrome associated with somatic UBA1 mutations leading to an AID affecting mostly elderly men. Diagnosis of monogenic AIDs is based on personal and family history and detailed analysis of symptoms associated with febrile attacks in the context of elevated peripheral inflammatory markers. This review proposes a practical approach for the diagnosis of the main monogenic AIDs among adult patients.

Identifiants

pubmed: 36575989
pii: 6964376
doi: 10.1093/rheumatology/keac712
doi:

Substances chimiques

MEFV protein, human 0
Pyrin 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2665-2672

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Marion Delplanque (M)

Sorbonne University, Internal Medicine Department, AP-HP, Tenon Hospital, Paris, France.
French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.

Antoine Fayand (A)

Sorbonne University, Internal Medicine Department, AP-HP, Tenon Hospital, Paris, France.
French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.

Guilaine Boursier (G)

French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.
Department of Molecular Genetics and Cytogenomics, Rare and Auto Inflammatory Diseases Unit, CHU Montpellier, University of Montpellier, Montpellier, France.

Gilles Grateau (G)

Sorbonne University, Internal Medicine Department, AP-HP, Tenon Hospital, Paris, France.
French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.

Léa Savey (L)

Sorbonne University, Internal Medicine Department, AP-HP, Tenon Hospital, Paris, France.
French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.

Sophie Georgin-Lavialle (S)

Sorbonne University, Internal Medicine Department, AP-HP, Tenon Hospital, Paris, France.
French National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA) France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH